Regulatory trial for selumetinib in children with symptomatic plexiform neurofibromas

syn58211567

Created By NF Service nf-osi-service

studyName: Regulatory trial for selumetinib in children with symptomatic plexiform neurofibromas
dataStatus: Data Not Expected
initiative: Partnership
studyLeads: Brian Weiss Michael Fisher
studyStatus: Complete
diseaseFocus: Neurofibromatosis type 1
institutions: Children's Hospital of Philadelphia
fundingAgency: NTAP
manifestation: Plexiform Neurofibroma
studyFileviewId: syn58211645
syn58211645

Regulatory trial for selumetinib in children with symptomatic plexiform neurofibromas page is loading…